Can a Culturally-Tailored therapy reduce anxiety in advanced cancer patients?
NCT ID NCT07225309
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This study tests whether a therapy called Meaning-Centered Psychotherapy for Latinos (MCP-L) can help reduce anxiety and depression in 300 Latino patients with advanced cancer. Participants receive either MCP-L or standard cognitive behavioral therapy over about 3 months. The goal is to see if focusing on meaning and cultural values improves emotional well-being and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Meaning-Centered Psychotherapy for Latinos (MCP-L), a structured 7-session therapy focusing on meaning and coping with advanced cancer
- What this could lead to
- If it works, this could offer a culturally tailored therapy to help Latino patients with advanced cancer feel less anxious and depressed.
- What could go wrong
- This is a behavioral intervention study, so results depend on participant engagement and may not apply to all groups. The therapy may not outperform standard CBT.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Apr 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patient Eligibility Criteria: A patient cannot be considered eligible for this study unless ALL of the following conditions are met. Participant eligibility will be determined by an initial EMR review followed by a self-report screener and suicide risk assessment. Inclusion Criteria: EMR Criteria \- Documentation of Disease * Pathologically confirmed breast, prostate, colorectal, thyroid, cervix, uteri, or lung - solid tumor cancer (either most recent or new diagnosis) * Definition of Disease \[or Measurable Disease\] * Diagnosed with stages III or IV * Prior Treatment * Receiving ambulatory care at INCan Self-Report Criteria * Age ≥ 18 years * Able to read and communicate in Spanish determined by the question: "Can you read and communicate in Spanish? Yes/No" * Professional role of administrators, clinicians (e.g., oncologists), mental health providers, supervised therapists-in-training (e.g., graduate students), or other related provider delivering the MCP-L experimental intervention * Providing care (or services) to Mexican cancer patients at INCan * Has access to internet and an electronic device * Agrees to be audio-recorded Exclusion Criteria: EMR Criteria * Prior Treatment * Received psychological or psychiatric care at INCan in the last 3 months * In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation * Diagnosed with a serious psychiatric condition Self-Report Criteria * Received psychological or psychiatric care outside of INCan in the last 3 months * Presence of suicide risk determined by the Columbia-Suicide Severity Rating Scale * Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?" Provider Eligibility Criteria: Inclusion Criteria Self-Report Criteria * Age ≥ 18 years * Able to read and communicate in Spanish determined by the question: "Can you read and communicate in Spanish? Yes/No" * Professional role of administrators, clinicians (e.g., oncologists), mental health providers, supervised therapists-in-training (e.g., graduate students), or other related provider delivering the MCP-L experimental intervention * Providing care (or services) to Mexican cancer patients at INCan * Has access to internet and an electronic device * Agrees to be audio-recorded
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Instituto Nacional de Cancerología (INCan)
NOT_YET_RECRUITINGMexico City, Mexico
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- A scanner in the operating room could show surgeons exactly where prostate cancer remains
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Gut bacteria may hold clues to why some cancer treatments work better